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The Editorial on the Research Topic
Glial Cells: Managers of Neuro-Immunity
After many decades of study in the field of Neuroscience that were mostly centered on the neuron
there is a mounting interest in the study of the function of the glial cells in many aspects and
functions of the central nervous system. The involvement of glial cells in neuroimmunity is one of
the critical pieces within this puzzle, and one that entails great complexity. An increasing number
of publications shows that resident astroglia and microglia are the real managers of immune
responses, orchestrating chemokine and cytokine release, blood cell infiltration, and promotion
of angiogenesis, etc. Moreover, each disease and neuroinflammatory scenario seems to have its
own distinct biochemical characteristics and glial phenotype. Classical definitions of resting and
activated microglial cells or pro-inflammatory and anti-inflammatory phenotypes are recognized
today as oversimplifiedmodels of glial cell functions and have since been surpassed bymore defined
and precise characterizations. The present Frontiers Research Topic (FRT) is a great example of
this, since the study of different scenarios reflects diverse modes of glial activation and distinct
complexities.
We present here a selection of articles, both original research and reviews, solving clinical, and
basic aspects of the biology of glial cells in neuro-inflammatory and neuro-immune scenarios.
A good number of manuscripts in this FRT shows the importance of glial cell-derived
inflammation on neurodegenerative diseases. Particularly, Ben Haim and colleagues, from
Escartin’s lab, show a compelling review on the peculiar, and still poorly understood, roles of
astrocytes in neurodegenerative diseases, unfolding the signaling pathways toward reactivity (Ben
Haim et al.). Von Bernhardi et al., review the roles of glial cells in neurodegeneration, but focused on
Alzheimer’s disease and particularly discussing the effects of the cytokine TGFβ (von Bernhardi et
al.). Herrera et al. center their attention on another major neurodegenerative disorder, Parkinson’s
disease, and how stress and glucocorticoids may interact and play important roles in modulating
microglial activation (Herrera et al.). Yuste and colleagues, give us an interesting view of the role of
nitric oxide in neurodegenerative diseases from a glial-derived inflammatory perspective (Yuste et
al.). Vieira et al., review the glial reaction triggered in multiple system atrophy (MSA) focused on
the α-synuclein-mediated activation (Vieira et al.).
Other papers are centered on Multiple Sclerosis. Crowley et al., for instance, present an
original paper characterizing the roles of Baclofen, a well-known GABA B receptor agonist used
clinically, for regulating TLR3 and TLR4 signaling in murine glial cells and peripheral monocytes
obtained from Multiple Sclerosis patients (Crowley et al.). Huseby and colleagues review another
aspect, focusing their manuscript on the amplification of the neuroinflammatory response due to
glial cells-T cell interactions (Huseby et al.). Almolda et al. from González and Castellano’s lab,
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also review the topic of glia-lymphocyte crosstalk but
compellingly covering other pathological scenarios, suggesting
that microglial cells are able to acquire a phenotype of dendritic
cells (Almolda et al.).
We also include articles reflecting that inflammatory glial
response is involved in mental and psychiatric alterations, which
include frontotemporal dementia associated with amyotrophic
lateral sclerosis (ALS), reviewed by Radford et al. and the
pathogenesis of delirium, reviewed by Sfera et al.
Due to its patent roles in neuro-immunity, microglial cells
and brain macrophages are the main protagonists of many of
the papers included in this FRT. We would like to highlight
the appealing work on the in vivo characterization of microglial
engulfment of dying neurons presented by Morsch et al., which
represents a fine piece of basic science (Morsch et al.). From a
clinical point of view, Spanos et al., review the roles of microglia
in brain infection, particularly in CNS tuberculosis and how
this may affect future therapeutic strategies (Spanos et al.).
Following the focus on microglia, Perrotta et al., present an
interesting perspective article on the importance of themicroglia-
glioma cells crosstalk in hormone and immune-derived response
in glioma (Perrotta et al.). Particularly important for glioma
is the modification of the phenotype, which varies from the
classically activated to pro-tumoral phenotype. In this context of
phenotype modulation, Kopitar-Jerala reviews the novel role of
the cystatin, statin B, in modulating microglial cells toward a pro
and anti-inflammatory response (Kopitar-Jerala). In a different
scenario, López-Pedrajas et al. report here that cocaine-treated
rats show microglial activation in the cerebellum, suggesting that
glial reaction may have important implications in motor control
during drug addiction (Lopez-Pedrajas et al.).
Importantly, for the field of the long-term maintenance of
the neuro-immune response, an interesting original article, Cao
et al., reports that prior activation of microglia during embryo
development may have consequences in the susceptibility to
inflammation in the life of the newborns (Cao et al.). This
advocates for the importance of glial cells driving lasting immune
responses. Finally, Bas et al., report that infiltrated macrophages
participate in the repair of spiral ganglion cells and neurons
forming the cochlear nerve, having important implications for
successful cochlear implant surgery (Bas et al.).
We believe that this comprehensive collection of articles
contains valuable information that will contribute to the
knowledge on how glial cells drive the management of neuro-
immunity. As the editorial team, we hope you enjoy reading,
Carlos Barcia, Gilles J Guillemin, James F. Curtin, Jeffrey M.
Zirger.
AUTHOR CONTRIBUTIONS
All authors listed, have made substantial, direct and intellectual
contribution to the work, and approved it for publication.
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2016 Barcia, Guillemin, Curtin and Zirger. This is an open-access
article distributed under the terms of the Creative Commons Attribution License
(CC BY). The use, distribution or reproduction in other forums is permitted,
provided the original author(s) or licensor are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which does not comply with these
terms.
Frontiers in Cellular Neuroscience | www.frontiersin.org 2 March 2016 | Volume 10 | Article 60
